As autumn moves to winter, the WHO/Europe, EC and ECDC are issuing a clear, urgent message: people who remain unprotected against both COVID-19 and seasonal influenza – especially the most vulnerable and at-risk – should take up any offer for vaccination to prevent or mitigate the impact of these co-circulating respiratory infections.
This document presents the core protocol for ECDC studies of CVE and IVE against symptomatic laboratory-confirmed influenza or SARS-CoV-2 infection, respectively, at primary care level.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 10-16 September 2023 and includes updates on COVID-19, diphtheria, West Nile virus, avian influenza, dengue, legionnaires' disease, the Rugby World Cup 2023, cutaneous Anthrax, pertussis, botulism and severe floods.
Since January 2022, and as of 11 August 2023, 281 confirmed diphtheria cases, as per the EU case definition (2022: 224 cases, 2023: 57 cases), and four deaths were reported in the EU/EEA.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 6 - 12 August 2023 and includes updates on measles, COVID-19, swine flu, mpox, diphtheria, West Nile virus, avian influenza, dengue, Crimean-Congo haemorrhagic fever, and invasive meningococcal disease.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 9-15 July 2023 and includes updates on avian influenza, West Nile virus, COVID-19, diphtheria, and vibrio.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 2-8 July 2023 and includes updates on avian influenza in domestic cats, pride celebrations, diphtheria, COVID-19, West Nile virus, mass gatherings, measles, Middle East respiratory syndrome coronavirus (MERS-CoV), Mpox, and Ralstonia mannitolilytica in dialysis patients.